-Next generation intravascular ultrasound catheter improves image quality and deliverability NATICK, Mass. -- The Boston Scientific Corporation has received U.S. Food and Drug Administration clearance ...
Drs. David Lee, Akiko Maehara, & Ziad Ali, discuss the value of new Opticross HD 60 MHz IVUS – from ease of image interpretation and no contrast PCI, to detection of fine structures not visible with ...
Intravascular ultrasound (IVUS) guidance during percutaneous coronary intervention (PCI) has been associated with increased stent optimization and reduced adverse events among patients with complex ...
The Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration clearance, CE Mark and Japan PMDA approval for its OptiCross™ Coronary Imaging Catheter and has launched ...
NATICK, Mass., July 24, 2013 /PRNewswire/ -- The Boston Scientific Corporation has received U.S. Food and Drug Administration clearance, CE Mark and Japan PMDA approval for its OptiCross(TM) Coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results